Effects of long-lasting angiotensin converting enzyme inhibitor, CV-33 on circadian changes of blood pressure at the homes of ambulatory patients with essential hypertension. Comparison between twice daily administration and once daily administration.

Enzyme Inhibitor ◽

Daily Administration ◽

Converting Enzyme ◽

Once Daily ◽

Circadian Changes ◽

Ambulatory Patients

Effects of Fosenopril, a Once-Daily Angiotensin-converting Enzyme Inhibitor, on Resting and Exercise-induced Changes of Blood Pressure, Hormonal Variables, and Plasma Potassium in Essential Hypertension

American Journal of Hypertension ◽

10.1093/ajh/1.3.280s ◽

1988 ◽

Vol 1 (3 Pt 3) ◽

pp. 280S-283S ◽

Cited By ~ 9

Author(s):

P. A. Sullivan ◽

M. Dineen ◽

J. Cervenka ◽

D. T. O'Connor

Keyword(s):

Blood Pressure ◽

Essential Hypertension ◽

Enzyme Inhibitor ◽

Plasma Potassium ◽

Converting Enzyme ◽

Once Daily ◽

Exercise Induced ◽

Induced Changes

Fosenopril, an angiotensin-converting enzyme inhibitor, and propranolol: Comparative effects at rest and exercise on blood pressure, hormonal variables, and plasma potassium in essential hypertension

Cardiovascular Drugs and Therapy ◽

10.1007/bf01881529 ◽

1989 ◽

Vol 3 (1) ◽

pp. 57-62 ◽

Cited By ~ 5

Author(s):

Patrick A Sullivan ◽

Justine Cervenka ◽

Daniel T. O'Connor ◽

Mary Dineen

Keyword(s):

Blood Pressure ◽

Essential Hypertension ◽

Enzyme Inhibitor ◽

Plasma Potassium ◽

Converting Enzyme ◽

Converting Enzyme Inhibitor ◽

Rest And Exercise

Effect of ramipril, a new angiotensin converting enzyme inhibitor, on diurnal variations of blood pressure in essential hypertension

The American Journal of Cardiology ◽

10.1016/0002-9149(87)90060-9 ◽

1987 ◽

Vol 59 (10) ◽

pp. D86-D91 ◽

Cited By ~ 5

Author(s):

Yoshihiro Kaneko ◽

Teruo Omae ◽

Kaoru Yoshinaga ◽

Osamu Iimura ◽

Yoshiaki Inagaki ◽

...

Keyword(s):

Blood Pressure ◽

Essential Hypertension ◽

Enzyme Inhibitor ◽

Diurnal Variations ◽

Converting Enzyme ◽

Twenty-four-hour blood pressure control using once daily treatment with a calcium antagonist or an angiotensin converting enzyme inhibitor

Journal of Hypertension ◽

10.1097/00004872-199112006-00170 ◽

1991 ◽

Vol 9 ◽

pp. S374 ◽

Cited By ~ 1

Author(s):

Ettore Malacco ◽

Roberto Fogari ◽

Franco Tettamanti ◽

Marina Magenta

Keyword(s):

Blood Pressure ◽

Calcium Antagonist ◽

Blood Pressure Control ◽

Enzyme Inhibitor ◽

Pressure Control ◽

Converting Enzyme ◽

Once Daily ◽

Twenty-four-hour blood pressure control using once daily treatment with a calcium antagonist or an angiotensin converting enzyme inhibitor

Journal of Hypertension ◽

10.1097/00004872-199112000-00170 ◽

1991 ◽

Vol 9 (6) ◽

pp. S374

Author(s):

Ettore Malacco ◽

Roberto Fogari ◽

Franco Tettamanti ◽

Marina Magenta

Keyword(s):

Blood Pressure ◽

Calcium Antagonist ◽

Blood Pressure Control ◽

Enzyme Inhibitor ◽

Pressure Control ◽

Converting Enzyme ◽

Once Daily ◽

A Common Haplotype onMethylenetetrahydrofolate ReductaseGene Modifies the Effect of Angiotensin-Converting Enzyme Inhibitor on Blood Pressure in Essential Hypertension Patients—A Family-Based Association Study

Clinical and Experimental Hypertension ◽

10.1081/ceh-200067686 ◽

2005 ◽

Vol 27 (6) ◽

pp. 509-521 ◽

Cited By ~ 9

Author(s):

Shanqun Jiang ◽

Yi-Hsiang Hsu ◽

Tianhua Niu ◽

Xin Xu ◽

Houxun Xing ◽

...

Keyword(s):

Blood Pressure ◽

Essential Hypertension ◽

Association Study ◽

Enzyme Inhibitor ◽

Common Haplotype ◽

Converting Enzyme ◽

Converting Enzyme Inhibitor ◽

Family Based

Comparison of blood pressure and angiotensin responses to the renin inhibitor Ro 42-5892 and the angiotensin converting enzyme inhibitor enalapril in essential hypertension

Journal of Hypertension ◽

10.1097/00004872-199308000-00010 ◽

1993 ◽

Vol 11 (8) ◽

pp. 831-838 ◽

Cited By ~ 19

Author(s):

Anton H. van den Meiracker ◽

Peter J.J. Admiraal ◽

Frans H.M. Derkx ◽

Cees Kleinbloesem ◽

Arie J. Man ??t Veld ◽

...

Keyword(s):

Blood Pressure ◽

Essential Hypertension ◽

Enzyme Inhibitor ◽

Renin Inhibitor ◽

Converting Enzyme ◽

Faculty Opinions recommendation of Effects on insulin action of adding low-dose thiazide to angiotensin-converting enzyme inhibitor in essential hypertension.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717985483.793473970 ◽

2013 ◽

Author(s):

Bo Carlberg ◽

Mattias Brunström

Keyword(s):

Essential Hypertension ◽

Insulin Action ◽

Low Dose ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

First dose response and 24-hour antihypertensive efficacy of the new once-daily angiotensin converting enzyme inhibitor, ramipril

The American Journal of Cardiology ◽

10.1016/0002-9149(88)90219-6 ◽

1988 ◽

Vol 62 (4) ◽

pp. 239-245 ◽

Cited By ~ 9

Author(s):

Mary E. Heber ◽

Geoffrey S. Brigden ◽

Michael P. Caruana ◽

Avijit Lahiri ◽

Edward B. Raftery

Keyword(s):

Dose Response ◽

Enzyme Inhibitor ◽

Antihypertensive Efficacy ◽

Converting Enzyme ◽

Once Daily ◽

Association Between Angiotensinogen, Angiotensin II Receptor Genes, and Blood Pressure Response to an Angiotensin-Converting Enzyme Inhibitor

Circulation ◽

10.1161/circulationaha.106.642058 ◽

2007 ◽

Vol 115 (6) ◽

pp. 725-732 ◽

Cited By ~ 51

Author(s):

Xiaowen Su ◽

Liming Lee ◽

Xiaohui Li ◽

Jun Lv ◽

Yonghua Hu ◽

...

Keyword(s):

Blood Pressure ◽

Angiotensin Ii ◽

Enzyme Inhibitor ◽

Blood Pressure Response ◽

Pressure Response ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽